Di Grazia, D.; Mirabella, C.; Chiara, F.; Caudana, M.; Shelton Agar, F.M.A.; Zanatta, M.; Allegra, S.; Bertello, J.; Voi, V.; Ferrero, G.B.;
et al. Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease. Pharmaceuticals 2024, 17, 1386.
https://doi.org/10.3390/ph17101386
AMA Style
Di Grazia D, Mirabella C, Chiara F, Caudana M, Shelton Agar FMA, Zanatta M, Allegra S, Bertello J, Voi V, Ferrero GB,
et al. Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease. Pharmaceuticals. 2024; 17(10):1386.
https://doi.org/10.3390/ph17101386
Chicago/Turabian Style
Di Grazia, Daniela, Cristina Mirabella, Francesco Chiara, Maura Caudana, Francesco Maximillian Anthony Shelton Agar, Marina Zanatta, Sarah Allegra, Jenni Bertello, Vincenzo Voi, Giovanni Battista Ferrero,
and et al. 2024. "Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease" Pharmaceuticals 17, no. 10: 1386.
https://doi.org/10.3390/ph17101386
APA Style
Di Grazia, D., Mirabella, C., Chiara, F., Caudana, M., Shelton Agar, F. M. A., Zanatta, M., Allegra, S., Bertello, J., Voi, V., Ferrero, G. B., Abbadessa, G., & De Francia, S.
(2024). Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease. Pharmaceuticals, 17(10), 1386.
https://doi.org/10.3390/ph17101386
